Does Dr. Yanbing Li have any related-party transactions with Equinix (EQIX)?

As of the report date, Equinix states that Dr. Yanbing Li is not a party, directly or indirectly, to any transaction requiring disclosure under Item 404(a) of Regulation S-K.

Equinix names Yanbing Li to board

Q: What board change did Equinix (EQIX) disclose in this filing?

Equinix disclosed that it elected Dr. Yanbing Li as an independent director to its Board of Directors, effective August 12, 2025.

Q: What committee will Dr. Yanbing Li serve on at Equinix (EQIX)?

Dr. Yanbing Li will serve as a member of Equinix’s Talent, Culture and Compensation Committee.

Q: Was Dr. Yanbing Li’s election to the Equinix (EQIX) board tied to any arrangements with third parties?

Equinix states that the election of Dr. Yanbing Li was not pursuant to any arrangement or understanding between her and any third party.

Equinix, Inc. reported that it has elected Dr. Yanbing Li as an independent director to its Board of Directors, effective August 12, 2025.

Accepted by SEC EDGAR 08/14/2025 - 05:19 PM EDT

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Equinix, Inc. reported that it has elected Dr. Yanbing Li as an independent director to its Board of Directors, effective August 12, 2025. With her election, the Board now consists of nine members. Dr. Li will serve on the Board’s Talent, Culture and Compensation Committee. The company states that her election was not made pursuant to any arrangement or understanding with a third party, and that she is not involved in any transactions requiring disclosure as related-party transactions. As a non-employee director, she will receive Equinix’s standard compensation for non-employee members of the Board.

8-K Event Classification

2 items: 5.02, 9.01

2 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What board change did Equinix (EQIX) disclose in this filing?

Equinix disclosed that it elected Dr. Yanbing Li as an independent director to its Board of Directors, effective August 12, 2025.

How many directors are on Equinix (EQIX)’s board after adding Dr. Yanbing Li?

After electing Dr. Yanbing Li, Equinix’s Board of Directors consists of nine members.

What committee will Dr. Yanbing Li serve on at Equinix (EQIX)?

Dr. Yanbing Li will serve as a member of Equinix’s Talent, Culture and Compensation Committee.

Was Dr. Yanbing Li’s election to the Equinix (EQIX) board tied to any arrangements with third parties?

Equinix states that the election of Dr. Yanbing Li was not pursuant to any arrangement or understanding between her and any third party.

How will Dr. Yanbing Li be compensated as a director at Equinix (EQIX)?

Equinix states that Dr. Yanbing Li will receive the company’s standard compensation for non-employee directors.

Did Equinix (EQIX) issue a press release about Dr. Yanbing Li’s election?

Yes. A press release relating to Dr. Yanbing Li’s election as a director is included as Exhibit 99.1, dated August 14, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (date of earliest event reported): August 12, 2025

EQUINIX, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-40205

77-0487526

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

One Lagoon Drive

Redwood City, California

94065

(Address of Principal Executive Offices)

(Zip Code)

(650) 598-6000

Registrant's telephone number, including area code

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001	EQIX	The Nasdaq Stock Market LLC
0.250% Senior Notes due 2027	N/A	The Nasdaq Stock Market LLC
1.000% Senior Notes due 2033	N/A	The Nasdaq Stock Market LLC
3.650% Senior Notes due 2033	N/A	The Nasdaq Stock Market LLC
3.250% Senior Notes due 2031	N/A	The Nasdaq Stock Market LLC
3.625% Senior Notes due 2034	N/A	The Nasdaq Stock Market LLC
3.250% Senior Notes due 2029	N/A	The Nasdaq Stock Market LLC
4.000% Senior Notes due 2034	N/A	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 5.02.			Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Election of Director

Equinix, Inc. (“Equinix”) has elected Dr. Yanbing Li as an independent director to its Board of Directors (the “Board”), effective August 12, 2025. With the election of Dr. Li, Equinix’s Board now consists of 9 members.

Dr. Li will serve as a member of the Board’s Talent, Culture and Compensation Committee.

The election of Dr. Li was not pursuant to any arrangement or understanding between Dr. Li and any third party. As of the date of this report, Dr. Li is not a party, either directly or indirectly, to any transaction that is required to be reported pursuant to Item 404(a) of Regulation S-K of the Securities Exchange Act of 1934, as amended.

As member of Equinix’s Board, Dr. Li will receive Equinix’s standard compensation for non-employee directors.

A copy of Equinix’s press release relating to the election of Dr. Li as a director is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.


Item 9.01.			Financial Statements and Exhibits.

(d) Exhibits.

99.1 Press Release of Equinix, Inc. dated August 14, 2025.

104 Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.